CLDX - Fibonacci setup ahead of potential clinical data ロング
Celldex Therapeutics, Inc.NASDAQ
詳細
⋅ Waiting on an update on Phase 2 trials in melanoma patients expected in Q4. Stock could rally from Fibonacci setup after the conference.
Buy zone: 2.70
Profit zone: 3.00 or higher
Stop zone: 2.55 or lower